Indication
Chronic Escherichia coli prostatitis
Chronic Escherichia coli prostatitis is a persistent, relapsing bacterial infection of the prostate gland in adult males, classified as National Institutes of Health Category II chronic bacterial prostatitis. Read more about Chronic Escherichia coli prostatitis
50 drugs 46 manufacturers
Drugs that treat it
Common Chronic Escherichia coli prostatitis therapies.
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN-D5W (levofloxacin/dextrose 5 % in water)
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic Escherichia coli prostatitis is a persistent, relapsing bacterial infection of the prostate gland in adult males, classified as National Institutes of Health Category II chronic bacterial prostatitis.
It occurs when uropathogenic *Escherichia coli* invades the prostate—frequently via intraprostatic reflux of infected urine or ascending urethral spread—and colonizes the glandular parenchyma, often forming protective biofilms or niduses within prostatic calculi.
Clinically, the condition is defined by recurrent urinary tract infections caused by the same bacterial strain interspersed with periods of lower urinary tract irritation, dysuria, pelvic or perineal discomfort, and painful ejaculation, typically persisting for at least three months without the acute systemic toxicity seen in acute prostatitis.
- nih.gov
Chronic Escherichia coli prostatitis is a persistent, relapsing bacterial infection of the prostate gland in adult males, classified as National Institutes of Health Category II chronic bacterial prostatitis
- nih.gov
Chronic Escherichia coli prostatitis is a persistent, relapsing bacterial infection of the prostate gland in adult males, classified as National Institutes of Health Category II chronic bacterial prostatitis Clinically, the condition is defined by recurrent urinary tract infections caused by the same bacterial strain interspersed with periods of lower urinary tract irritation, dysuria, pelvic or perineal discomfort, and painful ejaculation, typically persisting for at least three months without ...
- nih.gov
It occurs when uropathogenic *Escherichia coli* invades the prostate—frequently via intraprostatic reflux of infected urine or ascending urethral spread—and colonizes the glandular parenchyma, often forming protective biofilms or niduses within prostatic calculi
- clinicaltrials.eu
It occurs when uropathogenic *Escherichia coli* invades the prostate—frequently via intraprostatic reflux of infected urine or ascending urethral spread—and colonizes the glandular parenchyma, often forming protective biofilms or niduses within prostatic calculi Clinically, the condition is defined by recurrent urinary tract infections caused by the same bacterial strain interspersed with periods of lower urinary tract irritation, dysuria, pelvic or perineal discomfort, and painful ejaculation, ...
- racgp.org.au
It occurs when uropathogenic *Escherichia coli* invades the prostate—frequently via intraprostatic reflux of infected urine or ascending urethral spread—and colonizes the glandular parenchyma, often forming protective biofilms or niduses within prostatic calculi
- nih.gov
Clinically, the condition is defined by recurrent urinary tract infections caused by the same bacterial strain interspersed with periods of lower urinary tract irritation, dysuria, pelvic or perineal discomfort, and painful ejaculation, typically persisting for at least three months without the acute systemic toxicity seen in acute prostatitis
- clevelandclinic.org
Clinically, the condition is defined by recurrent urinary tract infections caused by the same bacterial strain interspersed with periods of lower urinary tract irritation, dysuria, pelvic or perineal discomfort, and painful ejaculation, typically persisting for at least three months without the acute systemic toxicity seen in acute prostatitis
Personalize your experience
Follow Chronic Escherichia coli prostatitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.